A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a machine to fix it. HIVE, modular robotic labs built by the company, can grow 20 kinds of human tissue, then autonomously dose and monitor them, generating the kind of causal biological data that today’s AI models are missing — data that today mostly comes from animal testing, or studies of single cells or proteins, not living tissue. “Absent human testing, what are these…
Why this update matters
This developing story is relevant for readers tracking technology because it reflects fresh changes from the original source and signals where attention is shifting next.
Key details
The report was collected automatically and prepared for publication with a newsroom workflow that focuses on clarity, search visibility, and quick understanding.
Readers should review the original source for direct statements, official notices, and any later corrections or additions as the story evolves.
Related coverage
Continue reading with more reporting from the same topic cluster.